Target
Tyrosine-protein kinase JAK2
Ligand
BDBM50243840
Substrate
n/a
Meas. Tech.
ChEMBL_1672944 (CHEMBL4022973)
IC50
5350±n/a nM
Citation
 Vazquez, MLKaila, NStrohbach, JWTrzupek, JDBrown, MFFlanagan, MEMitton-Fry, MJJohnson, TATenBrink, REArnold, EPBasak, AHeasley, SEKwon, SLangille, JParikh, MDGriffin, SHCasavant, JMDuclos, BAFenwick, AEHarris, TMHan, SCaspers, NDowty, MEYang, XBanker, MEHegen, MSymanowicz, PTLi, LWang, LLin, THJussif, JClark, JDTelliez, JBRobinson, RPUnwalla, R Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. J Med Chem 61:1130-1152 (2018) [PubMed]  Article
Target
Name:
Tyrosine-protein kinase JAK2
Synonyms:
JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase)
Type:
Protein
Mol. Mass.:
130684.68
Organism:
Homo sapiens (Human)
Description:
O60674
Residue:
1132
Sequence:
MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM50243840
Synonyms:
CHEMBL4085264
Type:
Small organic molecule
Emp. Form.:
C14H22N6O2S
Mol. Mass.:
338.428
SMILES:
CCN(C)S(=O)(=O)N[C@H]1C[C@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wD:10.12,8.7,(14.58,-6.2,;13.25,-6.97,;13.25,-8.51,;14.58,-9.28,;11.91,-9.28,;12.67,-10.61,;11.14,-10.6,;10.58,-8.52,;9.25,-9.29,;7.76,-8.9,;7.37,-10.39,;8.85,-10.78,;6.03,-11.17,;4.7,-10.4,;6.04,-12.71,;4.71,-13.48,;4.71,-15.02,;6.04,-15.79,;7.38,-15.01,;8.85,-15.48,;9.75,-14.23,;8.84,-12.99,;7.37,-13.47,)|
Structure:
Search PDB for entries with ligand similarity: